Worth Venture Partners’s Sanofi SNY Stock Holding History

Worth Venture Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,572	Closed	-$630K	–	202
2022 Q3	$630K	Buy	+16,572	New	+$738K	0.39%	67

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Worth Venture Partners's SNY Position: Q4 2022 in Review

Worth Venture Partners sold out of Sanofi (SNY) in Q4 2022, closing a stake of 16,572 shares — an estimated $630K sold.

Worth Venture Partners first reported a position in SNY in Q3 2022 and held it in 1 quarter. The position peaked at $630K in Q3 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Worth Venture Partners reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
Worth Venture Partners sold 16,572 Sanofi shares in Q4 2022, an estimated $630K.
Worth Venture Partners first reported a position in Sanofi in Q3 2022 and held it in 1 quarter.
Worth Venture Partners's Sanofi position peaked at $630K in Q3 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.